Protagenic Therapeutics Stock Market Value
| PTIX Stock | USD 0.73 0.08 12.31% |
| Symbol | Protagenic |
Protagenic Therapeutics Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Protagenic Therapeutics. If investors know Protagenic will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Protagenic Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.27) | Return On Assets (0.90) | Return On Equity (2.06) |
The market value of Protagenic Therapeutics is measured differently than its book value, which is the value of Protagenic that is recorded on the company's balance sheet. Investors also form their own opinion of Protagenic Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Protagenic Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Protagenic Therapeutics' market value can be influenced by many factors that don't directly affect Protagenic Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Protagenic Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Protagenic Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Protagenic Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Protagenic Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Protagenic Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Protagenic Therapeutics.
| 05/30/2024 |
| 11/26/2024 |
If you would invest 0.00 in Protagenic Therapeutics on May 30, 2024 and sell it all today you would earn a total of 0.00 from holding Protagenic Therapeutics or generate 0.0% return on investment in Protagenic Therapeutics over 180 days. Protagenic Therapeutics is related to or competes with Sino Biopharmaceutica, Eledon Pharmaceuticals, Rezolute, XOMA, Tempest Therapeutics, Aerovate Therapeutics, and Adagene. Protagenic Therapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutics to ... More
Protagenic Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Protagenic Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Protagenic Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 8.0 | |||
| Information Ratio | 0.0268 | |||
| Maximum Drawdown | 47.5 | |||
| Value At Risk | (12.07) | |||
| Potential Upside | 18.33 |
Protagenic Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Protagenic Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Protagenic Therapeutics' standard deviation. In reality, there are many statistical measures that can use Protagenic Therapeutics historical prices to predict the future Protagenic Therapeutics' volatility.| Risk Adjusted Performance | 0.0407 | |||
| Jensen Alpha | 0.5509 | |||
| Total Risk Alpha | (1.02) | |||
| Sortino Ratio | 0.0298 | |||
| Treynor Ratio | (0.22) |
Protagenic Therapeutics Backtested Returns
Protagenic Therapeutics appears to be abnormally volatile, given 3 months investment horizon. Protagenic Therapeutics maintains Sharpe Ratio (i.e., Efficiency) of 0.0557, which implies the firm had a 0.0557% return per unit of risk over the last 3 months. By analyzing Protagenic Therapeutics' technical indicators, you can evaluate if the expected return of 0.5% is justified by implied risk. Please evaluate Protagenic Therapeutics' Coefficient Of Variation of 2420.38, semi deviation of 7.0, and Risk Adjusted Performance of 0.0407 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Protagenic Therapeutics holds a performance score of 4. The company holds a Beta of -1.63, which implies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Protagenic Therapeutics are expected to decrease by larger amounts. On the other hand, during market turmoil, Protagenic Therapeutics is expected to outperform it. Please check Protagenic Therapeutics' potential upside, as well as the relationship between the accumulation distribution and period momentum indicator , to make a quick decision on whether Protagenic Therapeutics' historical price patterns will revert.
Auto-correlation | 0.10 |
Insignificant predictability
Protagenic Therapeutics has insignificant predictability. Overlapping area represents the amount of predictability between Protagenic Therapeutics time series from 30th of May 2024 to 28th of August 2024 and 28th of August 2024 to 26th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Protagenic Therapeutics price movement. The serial correlation of 0.1 indicates that less than 10.0% of current Protagenic Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.1 | |
| Spearman Rank Test | -0.09 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
Protagenic Therapeutics lagged returns against current returns
Autocorrelation, which is Protagenic Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Protagenic Therapeutics' stock expected returns. We can calculate the autocorrelation of Protagenic Therapeutics returns to help us make a trade decision. For example, suppose you find that Protagenic Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Protagenic Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Protagenic Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Protagenic Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Protagenic Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Protagenic Therapeutics Lagged Returns
When evaluating Protagenic Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Protagenic Therapeutics stock have on its future price. Protagenic Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Protagenic Therapeutics autocorrelation shows the relationship between Protagenic Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Protagenic Therapeutics.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Protagenic Stock Analysis
When running Protagenic Therapeutics' price analysis, check to measure Protagenic Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Protagenic Therapeutics is operating at the current time. Most of Protagenic Therapeutics' value examination focuses on studying past and present price action to predict the probability of Protagenic Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Protagenic Therapeutics' price. Additionally, you may evaluate how the addition of Protagenic Therapeutics to your portfolios can decrease your overall portfolio volatility.